You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
老百姓(603883.SH):擬2.1億元購買華康大藥房、江蘇百佳惠、泰州隆泰源剩餘股權
格隆匯 07-16 19:26

格隆匯7月16日丨老百姓(603883.SH)披露重大資產購買報吿書(草案),本次交易涉及的標的資產為少數股東持有的華康大藥房35%股權、江蘇百佳惠49%股權、泰州隆泰源49%股權。

公司擬向胡建中、崔旭芳及徐鬱平、海南奇泰支付現金2.095億元,購買胡建中持有的華康大藥房35%股權,購買崔旭芳及徐鬱平持有的江蘇百佳惠49%股權,購買海南奇泰持有的泰州隆泰源49%股權。

本次交易完成後,上市公司將持有華康大藥房100%股權、江蘇百佳惠100%股權、泰州隆泰源100%股權。上市公司上述購買資產交易均屬於醫藥行業收購事項。

本次交易前,老百姓已持有華康大藥房65%股權、江蘇百佳惠51%股權、泰州隆泰源51%股權。標的公司均已納入老百姓財務報表的合併範圍,本次收購事項對老百姓的主要財務指標無重大影響,歸屬母公司所有者的淨利潤將增加。

本次交易有利於上市公司對標的資產集權管理,整合上市公司資源,提升盈利能力。因三家標的公司地處經濟發達的江蘇地區且盈利狀況良好,提升股權佔比將提高上市公司盈利能力和完善江蘇省網絡佈局,收購還能提高少數股東積極性,促進星火併購公司的整合賦能和經營提效。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account